SEC Form 4 · accession 0001061983-19-000015
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark A Schlossberg
Officer — SVP - Legal & General Counsel
Period of report
Jan 31, 2019
Accepted (ET)
Feb 4, 2019 · 4:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $7.03 | Jan 31, 2019 | A | 44,756 | A | — | Jan 31, 2029 | Common Stock | 44,756 | 44,756 | D |
| Non-Qualified Stock Option (right to buy)F1 | $7.03 | Jan 31, 2019 | A | 55,244 | A | — | Jan 31, 2029 | Common Stock | 55,244 | 55,244 | D |
Explanation of responses
- F1When the ISO and NQ dated 01/31/2019 are combined for a total grant of 100,000 shares, the option shall vest and become exercisable as to 25,000 shares on 01/31/2020 and the balance of 75,000 divided into equal monthly installments thereafter such that the option shall be 100% vested on 01/31/2023.